FOLLOW US

  • facebook
  • twitter
Thu

March 12, 2026

Eikon's Upsized $381M IPO

America February 5, 2026

Eikon’s Upsized $381M IPO Ignites Nasdaq Debut

Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…

By Rachel Moore

primeGen us to go public

America February 4, 2026

primeGen US to Go Public in $1.5 Billion SPAC Deal

Biotech company PrimeGen US will go public in the United States through a $1.5 billion business combination with blank-check firm…

By Rachel Moore

MapLight $251M IPO

America October 27, 2025

MapLight $251M IPO Defies Market Slowdown Amid Federal Shutdown

In a bold move against a backdrop of federal uncertainty, MapLight Therapeutics has gone public, raising $251 million in its…

By Rihem Akkouche

Aardvark $94M IPO

America February 13, 2025

Aardvark Lands $94M IPO as Biotech Wave Gains Momentum

Aardvark Therapeutics Inc. made its public market debut Thursday, securing $94 million in its initial public offering (IPO). The obesity-focused…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter